WUXI BIO(02269) - 2025 Q4 - Earnings Call Transcript

WuXi Biologics (SEHK:02269) H2 2025 Earnings call March 25, 2026 08:00 AM ET Speaker1This call will be conducted in English. My name is Laurence Tam, China Healthcare Analyst at Morgan Stanley. Tonight, we're honored to have the management team of WuXi Biologics present to us their 2025 annual results. We have Dr. Chris Chen, who is the CEO of WuXi Biologics, Mr. Ming Tu, CFO of WuXi Biologics, Dr. Lina Fan, the head of IR team, and Willis Wu, also part of the WuXi Biologics IR team. The call will last for ...